The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Home

Found 8 results
Filters: Author is Thomas Lung
2017
Atkins E, Lung T, Redfern J. Combination Pills for Treatment of High Blood Pressure: Cost-effectiveness in The Asia Pacific Region. Heart Lung Circ. 2017;26(4):313-315. doi:10.1016/j.hlc.2017.02.001.
Lung T, Jan S, Stickney B, Edwards B, Milat A. Commissioning Economic Evaluations: A Guide. 2017. Available at: http://www.health.nsw.gov.au/research/Pages/population-health-guidance-series.aspx.
Lung T, Howard K, Etherton-Beer C, Sim M, Lewin G, Arendts G. Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting. PLoS One. 2017;12:e0172796.
Angell B, Laba T-L, Lung T, et al. Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease. Int J Equity Health. 2017;16(1):108. doi:10.1186/s12939-017-0610-2.
Hua X, Lung T, Palmer A, Si L, Herman WH, Clarke P. How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review. Pharmacoeconomics. 2017;35:319-329.
Hayes AJ, Lung T, Bauman A, Howard K. Modelling obesity trends in Australia: unravelling the past and predicting the future. Int J Obes (Lond). 2017;41:178-185.
2016
Lung T, Muhunthan J, Laba TL, Shiell A, Milat A, Jan S. Making guidelines for economic evaluations relevant to public health in Australia. Aust N Z J Public Health. 2016.
Petrie D, Lung T, Rawshani A, et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia. 2016;59(6):1167-76. doi:10.1007/s00125-016-3914-7.